PERTANIKA JOURNAL OF SCIENCE AND TECHNOLOGY

 

e-ISSN 2231-8526
ISSN 0128-7680

Home / Regular Issue / JST Vol. 25 (4) Dec. 2017 / JSSH-1647-2016

 

Short Communication: An Improved Risks and Benefits Assessment Tool for Institutional Review Boards

Wei-Hong Lai, Tze-Ming Ho and Zainanda Zainal

Pertanika Journal of Science & Technology, Volume 25, Issue 4, December 2017

Keywords: Risks and benefits assessment, bioethics

Published on: 5 Dec 2017

Ethical oversight is a critical requirement to conduct clinical research involving human participants and Institutional Review Board (IRB) and it is responsible to evaluate the ethical elements of a clinical research. However, there is no consensus on criteria for evaluating risks and benefits to human participants. Therefore, this article reviews the evaluation of risks and the potential benefits of a clinical trial using Multi-Attribute Utility Theory (MAUT) and suggests the incorporation of 5 levels of likelihood that risk event will occur for the standardisation of risk and benefit utility values.

ISSN 0128-7680

e-ISSN 2231-8526

Article ID

JSSH-1647-2016

Download Full Article PDF

Share this article

Recent Articles